Bipolar Research - Bipolar Disorder, Symptoms, Treatment, Depression, Medication

Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.


Bipolar Research Today

Home

View Latest Issue

Information About Bipolar

Books on Bipolar

Advertising in Research Today

View Other Research Today Publications



Volume 5 (2008), Issue 6 (June)

  1. Neuronal Peroxisome Proliferator-Activated Receptor gamma Signaling: Regulation by Mood-Stabilizer Valproate.
    J Mol Neurosci, 35(2): 225-34. [Abstract] [Full-text]
  2. Emotional memory in bipolar disorder.
    Br J Psychiatry, 192(6): 458-63. [Abstract] [Full-text]
  3. Executive dysfunction in elderly bipolar manic patients.
    Am J Geriatr Psychiatry, 16(6): 506-12. [Abstract] [Full-text]
  4. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Eur Neuropsychopharmacol, 18(7): 535-49. [Abstract] [Full-text]
  5. Randomized study comparing postoperative pain between coblation and bipolar scissor tonsillectomy.
    Eur Arch Otorhinolaryngol, 265(7): 817-20. [Abstract] [Full-text]
  6. Expression of cellular prion protein (PrP(c)) in schizophrenia, bipolar disorder, and depression.
    J Neural Transm, 115(5): 761-71. [Abstract] [Full-text]
  7. G72 and its association with major depression and neuroticism in large population-based groups from Germany.
    Am J Psychiatry, 165(6): 753-62. [Abstract] [Full-text]
  8. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.
    J Psychiatr Pract, 14(3): 160-9. [Abstract] [Full-text]
  9. Genes and neuroimaging: advances in psychiatric research.
    Neurodegener Dis, 5(5): 277-85. [Abstract] [Full-text]
  10. Editorial review: Shifting views on juvenile bipolar disorder and pervasive developmental disorder.
    Curr Opin Psychiatry, 21(4): 328-31. [Abstract] [Full-text]
  11. Failure of filgrastim to prevent severe clozapine-induced agranulocytosis.
    South Med J, 101(6): 639-40. [Abstract] [Full-text]
  12. The PDLIM5 gene and lithium prophylaxis: An association and gene expression analysis in Sardinian patients with bipolar disorder.
    Pharmacol Res, 57(5): 369-73. [Abstract] [Full-text]
  13. Photopic ON- and OFF-responses in complete type of congenital stationary night blindness in relation to stimulus intensity.
    Doc Ophthalmol, 117(1): 37-46. [Abstract] [Full-text]
  14. Effect of chronic lithium treatment on D2/3 autoreceptor regulation of dopaminergic function in the rat.
    Pharmacol Biochem Behav, 90(2): 218-25. [Abstract] [Full-text]
  15. Gender differences in associations between body mass index and DSM-IV mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Ann Epidemiol, 18(6): 458-66. [Abstract] [Full-text]
  16. Quantitative analysis of the 4977-bp common deletion of mitochondrial DNA in postmortem frontal cortex from patients with bipolar disorder and schizophrenia.
    Neurosci Lett, 439(2): 173-7. [Abstract] [Full-text]
  17. Counselor and Client Characteristics in Mental Health versus Substance Abuse Treatment Settings Providing Services for Co-Occurring Disorders.
    Community Ment Health J, 44(3): 155-69. [Abstract] [Full-text]
  18. Usefulness of the Spanish version of the mood disorder questionnaire for screening bipolar disorder in routine clinical practice in outpatients with major depression.
    Clin Pract Epidemol Ment Health, 4: 14. [Abstract] [Full-text]
  19. Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder.
    Cell Calcium, 44(1): 92-102. [Abstract] [Full-text]
  20. Six-year outcomes in first admission adolescent inpatients: clinical and cognitive characteristics at admission as predictors.
    Psychiatry Res, 160(1): 47-54. [Abstract] [Full-text]
  21. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Psychiatry Res, 160(1): 55-62. [Abstract] [Full-text]
  22. Impact of remitted substance use disorders on the future course of bipolar I disorder: findings from a clinical trial.
    Psychiatry Res, 160(1): 63-71. [Abstract] [Full-text]
  23. Attitudes to genetic testing in families with multiple cases of bipolar disorder.
    Genet Test, 12(2): 233-43. [Abstract] [Full-text]
  24. Clinical trial of wellness training: health promotion for severely mentally ill adults.
    J Nerv Ment Dis, 196(6): 475-83. [Abstract] [Full-text]
  25. Caregiver burden and health in bipolar disorder: a cluster analytic approach.
    J Nerv Ment Dis, 196(6): 484-91. [Abstract] [Full-text]
  26. Suicidality and its association with insight and neurocognition in taiwanese patients with bipolar I disorder in remission.
    J Nerv Ment Dis, 196(6): 462-7. [Abstract] [Full-text]
  27. Relationship between insight and neurocognition in patients with bipolar I disorder in remission.
    Compr Psychiatry, 49(4): 335-9. [Abstract] [Full-text]
  28. Mental disorder and threats made by noninstitutionalized people with weapons in the national comorbidity survey replication.
    J Nerv Ment Dis, 196(6): 437-45. [Abstract] [Full-text]
  29. Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function.
    Mol Psychiatry, 13(7): 685-96. [Abstract] [Full-text]
  30. Psychiatric genetics: progress amid controversy.
    Nat Rev Genet, 9(7): 527-40. [Abstract] [Full-text]
  31. Association of tumor necrosis factor -308G/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population.
    Neuropsychobiology, 57(1): 88-94. [Abstract] [Full-text]
  32. Effect of the methylenetetrahydrofolate reductase gene polymorphisms on homocysteine, folate and vitamin B12 in patients with bipolar disorder and relatives.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(5): 1331-7. [Abstract] [Full-text]
  33. Increased hexosaminidase activity in antipsychotic-induced extrapyramidal side effects: Possible association with higher occurrence in bipolar disorder patients.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(5): 1214-20. [Abstract] [Full-text]
  34. State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(5): 1199-205. [Abstract] [Full-text]
  35. The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depression.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(5): 1195-8. [Abstract] [Full-text]
  36. Shared gene expression alterations in schizophrenia and bipolar disorder.
    Biol Psychiatry, 64(2): 89-97. [Abstract] [Full-text]
  37. Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward task.
    Biol Psychiatry, 64(2): 162-8. [Abstract] [Full-text]
  38. Promoter variant in the GRK3 gene associated with bipolar disorder alters gene expression.
    Biol Psychiatry, 64(2): 104-10. [Abstract] [Full-text]
  39. Association analysis of monoamine oxidase A gene and bipolar affective disorder in Han Chinese.
    Behav Brain Funct, 4: 21. [Abstract] [Full-text]
  40. DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients.
    Neurosci Lett, 440(2): 150-4. [Abstract] [Full-text]
  41. A 7 Mb duplication at 22q13 in a girl with bipolar disorder and hippocampal malformation.
    Am J Med Genet A, 146(13): 1754-60. [Abstract] [Full-text]
  42. Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia.
    Brain Res, 1218: 267-77. [Abstract] [Full-text]
  43. Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin.
    Exp Cell Res, 314(11): 2279-88. [Abstract] [Full-text]
  44. Acute dextro-amphetamine administration does not alter brain myo-inositol levels in humans and animals: MRS investigations at 3 and 18.8 T.
    Neurosci Res, 61(4): 351-9. [Abstract] [Full-text]
  45. Novel linkage to chromosome 20p using latent classes of psychotic illness in 270 Irish high-density families.
    Biol Psychiatry, 64(2): 121-7. [Abstract] [Full-text]
  46. Family-based SNP association study on 8q24 in bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 147(5): 612-8. [Abstract] [Full-text]
  47. Further evidence for shared genetic effects between psychotic bipolar disorder and P50 suppression: A combined twin and family study.
    Am J Med Genet B Neuropsychiatr Genet, 147(5): 619-27. [Abstract] [Full-text]
  48. Involvement of the role of Chk1 in lithium-induced G2/M phase cell cycle arrest in hepatocellular carcinoma cells.
    J Cell Biochem, 104(4): 1181-91. [Abstract] [Full-text]
  49. Elucidating semantic disorganisation from a word comprehension task: Do patients with schizophrenia and bipolar disorder show differential processing of nouns, verbs and adjectives?
    Schizophr Res, 102(1): 63-68. [Abstract] [Full-text]
  50. Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia.
    Schizophr Res, 102(1): 210-9. [Abstract] [Full-text]
  51. Tyrosine hydroxylase immunoreactivity in the locus coeruleus is elevated in violent suicidal depressive patients.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
  52. Menstrual cycle dysfunction associated with neurologic and psychiatric disorders: their treatment in adolescents.
    Ann N Y Acad Sci, 1135: 219-29. [Abstract] [Full-text]
  53. "I actually don't know who I am": the impact of bipolar disorder on the development of self.
    Psychiatry, 71(2): 123-33. [Abstract] [Full-text]
  54. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics.
    Hum Psychopharmacol, 23(5): 417-24. [Abstract] [Full-text]
  55. BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments.
    Proc Natl Acad Sci U S A, 105(25): 8766-71. [Abstract] [Full-text]
  56. The Art of Prescribing Pharmacological Management of Adult ADHD: Implications for Psychiatric Care.
    Perspect Psychiatr Care, 44(3): 196-201. [Abstract] [Full-text]
  57. Postoperative complications in the seriously mentally ill: a systematic review of the literature.
    Ann Surg, 248(1): 31-8. [Abstract] [Full-text]
  58. New-onset psychiatric disorders in individuals with autism.
    Autism, 12(4): 373-90. [Abstract] [Full-text]
  59. Psychosis and autism as diametrical disorders of the social brain.
    Behav Brain Sci, 31(3): 241-61; discussion 261-320. [Abstract] [Full-text]
  60. Social support and adaptation of Taiwanese adults with mental illness.
    J Clin Nurs, 17(13): 1795-802. [Abstract] [Full-text]
  61. Lithium toxicity precipitated by profound hypothyroidism.
    Thyroid, 18(6): 651-4. [Abstract] [Full-text]
  62. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.
    Acta Psychiatr Scand, 118(1): 4-18. [Abstract] [Full-text]
  63. Models of mania and antimanic drug actions: progressing the endophenotype approach.
    J Psychopharmacol. [Abstract] [Full-text]
  64. Correlates of subjective and objective burden among caregivers of patients with bipolar disorder.
    Acta Psychiatr Scand, 118(1): 49-56. [Abstract] [Full-text]
  65. Comorbidity of conduct disorder and bipolar disorder in clinically referred children and adolescents.
    J Child Adolesc Psychopharmacol, 18(3): 271-9. [Abstract] [Full-text]
  66. Neurocognitive allied phenotypes for schizophrenia and bipolar disorder.
    Schizophr Bull, 34(4): 743-59. [Abstract] [Full-text]
  67. Psychosis endophenotypes in schizophrenia and bipolar disorder.
    Schizophr Bull, 34(4): 720-1. [Abstract] [Full-text]
  68. Neurophysiological endophenotypes across bipolar and schizophrenia psychosis.
    Schizophr Bull, 34(4): 760-73. [Abstract] [Full-text]
  69. Approaches for unraveling the joint genetic determinants of schizophrenia and bipolar disorder.
    Schizophr Bull, 34(4): 791-7. [Abstract] [Full-text]
  70. Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective.
    Curr Med Res Opin. [Abstract] [Full-text]
  71. Medical emergency department utilization patterns among uninsured patients with psychiatric disorders.
    Psychiatr Serv, 59(7): 808-11. [Abstract] [Full-text]
  72. Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial.
    Psychiatr Serv, 59(7): 760-8. [Abstract] [Full-text]
  73. Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder.
    Psychiatr Serv, 59(7): 753-9. [Abstract] [Full-text]
  74. Metabolic syndrome in Italian patients with bipolar disorder.
    Gen Hosp Psychiatry, 30(4): 318-23. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2013 Bipolar Research Today. All Rights Reserved.



Bipolar Research Today Archive:

Volume 1 (2004)
  Issue 1 (September)
  Issue 2 (October)
  Issue 3 (November)
  Issue 4 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 10 (2013)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)



Bipolar Books

The Natural Medicine Guide to Bipolar Disorder (The Healthy Mind Guides)

The Natural Medicine Guide to Bipolar Disorder (The Healthy Mind Guides)